Concepedia

Peter Libby

PL

Statistics

Publications

9

Citations

12.5K

H-Index

9

Active since

1999

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Novartis (Switzerland)

Novartis (United States)

Universidade de São Paulo

Peter Libby is an author at Brigham and Women's Hospital specializing in inflammation, medicine, and cardiovascular disease.

Publications per year

1999–2025

9

Publications

9

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

, , +17

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

, , +13

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Paul M. Ridker, Jean MacFadyen, Peter Libby et al. · The Lancet · 2017 · 886 citations · Full text

, , +8

Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy

Koïchi Shimizu, Seigo Sugiyama, Masanori Aikawa et al. · Nature Medicine · 2001 · 495 citations

, , +16

Cystatin C deficiency in human atherosclerosis and aortic aneurysms

Guo-Ping Shi, Galina K. Sukhova, Anders Grubb et al. · Journal of Clinical Investigation · 1999 · 448 citations · Full text

, , +15

1–5 of 9